Nyree Kibarian

Marketing Manager at @CBI_Conferences | Digital Marketing Enthusiast | Bubble Tea Addict | History Junkie | Religion: Boston Bruins | Opinions are my own

[Nyree Kibarian @NyreeCBI]

Daylight isn't the only thing you'll save this week! Early rates end Friday for 3 CBI events! http://t.co/aNI7M3Ao07

[Nyree Kibarian @NyreeCBI]

RT @DrugChannels UPDATE: #GPO Membership Eligibility and Class of Trade Maintenance = 3/30/15 http://t.co/kjhHg8IUlw

[Nyree Kibarian @NyreeCBI]

CBI's Clinical Enterprise Architecture & Data Governance conference agenda is ready to view! Download today! #clinops http://t.co/8ZKkTT3E2F

[Nyree Kibarian @NyreeCBI]

Social Media #Compliance Summit for #pharma is back-DL agenda & discover insights you'll gain! http://t.co/dByXPavNFF

[Nyree Kibarian @NyreeCBI]

Interested in the policies supporting the introduction of #biosimilar therapies? DL conference brochure #pharma! http://t.co/6JTq9hneVQ

[Nyree Kibarian @NyreeCBI]

Only 4 weeks left until CBI's Forging ACO Partnerships conference! Download the brochure today to learn more! #pharma http://t.co/o59x428bZN

[Nyree Kibarian @NyreeCBI]

What does the OECD recommend? Download Complimentary OECD Report on BEPS from @PwC_LLP! #tax #transferpricing #PLS http://t.co/JgsMQUHqng

[Nyree Kibarian @NyreeCBI]

Last day to take advantage of early bird pricing! #accountablecare #pharma #gpo #aco http://t.co/qkUNBdEmMz

[Nyree Kibarian @NyreeCBI]

What's the buzz about? DL the agenda for #CommercialData 2014 & find out! #data #MDM #aggspend http://t.co/uYieBtDRzt

[Nyree Kibarian @NyreeCBI]

INFOGRAPHIC: Seizing a Rare Opportunity- A Current Snapshot of the #RareDisease Community http://t.co/FP1ON0zvDV

[Nyree Kibarian @NyreeCBI]

RT @DrugChannels Real-World Data/Late Phase Summit http://t.co/b2xJhvJhka

[Nyree Kibarian @NyreeCBI]

"Saving Eliza | Rare Disease Dialog Blog" http://t.co/6EO7Hh3sNX by @RareDiseases #NORD2014 #raredisease #orphandrugs

[Nyree Kibarian @NyreeCBI]

5 Initiatives to Advance Research into Rare Disease Therapies http://t.co/xUYtW2HhpE #NORD2014 #raredisease

[Nyree Kibarian @NyreeCBI]

Matthew Boyd, Dir, Digital & Social Media @EMDSerono to speak @CBI_Conferences Social Media Compliance Summit http://t.co/9qyVLoSKob #hcsm

[Nyree Kibarian @NyreeCBI]

Register for Real-World Data/Late Phase Summit before 9/5 & save $300! #clincaltrials http://t.co/2FW1A2reYL

[Nyree Kibarian @NyreeCBI]

Mark Senak, Author/Editor "Eye on FDA" & Partner @Fleishman to speak @CBI_Conferences Social Media Compliance Summit http://t.co/hNvJBe8jjD

[Nyree Kibarian @NyreeCBI]

Review the challenging implications posed by @Wikipedia for your #pharma brand in wave of #FDA guidance http://t.co/IyghRvsKAG #hcsm

[Nyree Kibarian @NyreeCBI]

Join keynote speaker Margaret A. Hamburg, MD, Commissioner @US_FDA @RareDiseases & Orphan Products Summit http://t.co/G83JIf8waF #NORD2014

[Nyree Kibarian @NyreeCBI]

Howard Doffman, VP & General Counsel at Ferring Pharmaceuticals on Social Media http://t.co/SEjVqRTE1s #hcsm

[Nyree Kibarian @NyreeCBI]

Get Payer perspectives on the impact of coverage programs & #ACA on #raredisease research @RareDiseases & Orphan Products Summit #NORD2014